Prof. Guido J. K. Tricot

University of Iowa Hospitals and Clinics, USA

Email: [email protected]

Qualifications

1984 Ph.D., University of Leuven, Belgium

1975 M.D., University of Leuven, Belgium

Publications (selected)

1. Hao, M., Barlogie, B., Tricot, G. and Zhan, F. Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia. Clinical Cancer Research, 2019.
2. Kollu, V., Mott, S.L., Khan, R. and Tricot, G. C-Reactive Protein Monitoring Predicts Neutropenic Fever Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma. Cureus, 2018.
3. Franqui Machin, R., Hao, M., Bai, H. and Zhan, F. Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. The Journal of Clinical Investigation, 2018.
4. Khan, R., Mott, S.L., Schultz, A. and Tricot, G. Bloodless tandem autologous transplant in Jehovah’s Witness patients. Bone Marrow Transplantation, 2018.
5. Gu, C., Holman, C.J., Sompallae, R. and Janz, S. Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome. Blood Cancer Journal, 2018.
6. Gu, Z., Xia, J., Xu, H. and Zhan, F. NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase. Journal of Hematology & Oncology, 2017.
7. Zhan, X., Yu, W., Franqui Machin, R. and Tricot, G. Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma. Oncotarget, 2017.
8. Hao, M., Franqui Machin, R., Xu, H. and Zhan, F. myeloma. Leukemia, 2017.
9. Nadiminti, K., Pilla, S.V., Abbi, K.K.S. and Tricot, G. Incidence of Fungal Infections Associated with the Use of Novel Agents As Part of Conditioning Regimen during Autologous Stem Cell Transplant in Multiple Myeloma; A Single Center Experience at the University of Iowa. Biology of Blood and Marrow Transplantation, 2017.
10. Birmann, B.M., Andreotti, G., De Roos, A. and Purdue, M.P. Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC). Cancer Epidemiology, Biomarkers & Prevention, 2017.
11. Xia, J., Xu, H., Zhang, X. and Zhan, F. Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid. EBioMedicine, 2017.
12. Nadiminti, K., Abbi, K.K.S., Mott, S.L. and Tricot, G. VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma. OncoTargets and Therapy, 2017.
13. Rand, K.A., Song, C., Dean, E. and Cozen, W. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiology, Biomarkers & Prevention, 2016.
14. Schinasi, L., Brown, E.E., Camp, N.J. and De Roos, A. Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium. British Journal of Haematology, 2016.
15. Abbi, K.K.S., Silverman, M., Farooq, U. and Tricot, G. Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma. British Journal of Haematology, 2016.
16. Gu, C., Yang, Y., Sompallae, R. and Janz, S. FOXM1 is a therapeutic target for high-risk multiple myeloma. Leukemia, 2016.
17. Swami, U., Abbi, K.K.S., Dozeman, L.R. and Tricot, G. Cytomegalovirus and Human Herpes Virus-6 Reactivation Following Tandem Transplantation Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma (MM). Biology of Blood and Marrow Transplantation, 2016.
18. Han, S.-S., Tompkins, V.S., Son, D.J. and Janz, S. CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma. Experimental Hematology and Oncology, 2015.

Personal Details

https://www.patientpower.info/bio/guido-tricot-md-phd

https://www.longdom.org/editor/guido-jk-tricot-10436

https://www.researchgate.net/profile/Guido-Tricot